Literature DB >> 19075037

Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior.

Hans K Ghayee1, Bas Havekes, Eleonora P M Corssmit, Graeme Eisenhofer, Stephen R Hammes, Zahid Ahmad, Alexander Tessnow, Ivica Lazúrová, Karen T Adams, Antonio T Fojo, Karel Pacak, Richard J Auchus.   

Abstract

Extra-adrenal pheochromocytomas, otherwise known as paragangliomas (PGLs), account for about 20% of catecholamine-producing tumors. Catecholamine excess and mutations in the genes encoding succinate dehydrogenase subunits (SDHx) are frequently found in patients with PGLs. Only 2% of PGLs are found in the mediastinum, and little is known about genetic alterations in patients with mediastinal PGLs, catecholamine production by these tumors, or their clinical behavior. We hypothesized that most mediastinal PGLs are associated with germ line SDHx mutations, norepinephrine and/or dopamine excess, and aggressive behavior. The objective of this study was to characterize genetic, biochemical, and clinical data in a series of ten patients with mediastinal PGLs. All ten primary mediastinal PGL patients had germ line SDHx mutations, six in SDHB, and four in SDHD genes. Chest or back pain were the most common presenting symptoms (five patients), and catecholamines and/or their metabolites were elevated in seven patients. Additional tumors included head and neck PGLs in four patients, pheochromocytoma in one patient, and bladder PGL in another. Metastatic disease was documented in six patients (60%), and a concurrent abdominal mass was found in one patient. We conclude that mediastinal PGLs are strongly associated with SDHB and SDHD gene mutations, noradrenergic phenotype, and aggressive behavior. The present data suggest that all patients with mediastinal PGLs should be screened for SDHx gene mutations, regardless of age.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075037      PMCID: PMC4718401          DOI: 10.1677/ERC-08-0214

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  27 in total

1.  Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene.

Authors:  B Havekes; E P M Corssmit; J C Jansen; A G L van der Mey; A H J T Vriends; J A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2007-01-16       Impact factor: 5.958

2.  Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.

Authors:  Henri J L M Timmers; Anna Kozupa; Graeme Eisenhofer; Margarita Raygada; Karen T Adams; Daniel Solis; Jacques W M Lenders; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

3.  Management of an anterior mediastinal pheochromocytoma causing tracheomalacia.

Authors:  Bradley G Leshnower; Rohinton J Morris; Taine T V Pechet
Journal:  Ann Thorac Surg       Date:  2007-12       Impact factor: 4.330

4.  Mediastinal paraganglioma: radiologic evaluation of an unusual vascular tumor.

Authors:  E A Drucker; T C McLoud; C G Dedrick; A D Hilgenberg; S C Geller; J A Shepard
Journal:  AJR Am J Roentgenol       Date:  1987-03       Impact factor: 3.959

Review 5.  Management of delayed intracranial and intraspinal metastases of intradural spinal paragangliomas.

Authors:  L Thines; J P Lejeune; M M Ruchoux; R Assaker
Journal:  Acta Neurochir (Wien)       Date:  2005-11-09       Impact factor: 2.216

6.  Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

Authors:  Diana E Benn; Anne-Paule Gimenez-Roqueplo; Jennifer R Reilly; Jérôme Bertherat; John Burgess; Karen Byth; Michael Croxson; Patricia L M Dahia; Marianne Elston; Oliver Gimm; David Henley; Philippe Herman; Victoria Murday; Patricia Niccoli-Sire; Janice L Pasieka; Vincent Rohmer; Kathy Tucker; Xavier Jeunemaitre; Deborah J Marsh; Pierre-François Plouin; Bruce G Robinson
Journal:  J Clin Endocrinol Metab       Date:  2005-11-29       Impact factor: 5.958

Review 7.  Thoracic involvement with pheochromocytoma: a review.

Authors:  S Sandur; A Dasgupta; J L Shapiro; A C Arroliga; A C Mehta
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

8.  Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.

Authors:  Graeme Eisenhofer; David S Goldstein; Patricia Sullivan; Gyorgy Csako; Frederieke M Brouwers; Edwin W Lai; Karen T Adams; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2005-01-11       Impact factor: 5.958

9.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.

Authors:  Hartmut P H Neumann; Christian Pawlu; Mariola Peczkowska; Birke Bausch; Sarah R McWhinney; Mihaela Muresan; Mary Buchta; Gerlind Franke; Joachim Klisch; Thorsten A Bley; Stefan Hoegerle; Carsten C Boedeker; Giuseppe Opocher; Jörg Schipper; Andrzej Januszewicz; Charis Eng
Journal:  JAMA       Date:  2004-08-25       Impact factor: 56.272

Review 10.  Anterior and middle mediastinum paraganglioma: complete resection is the treatment of choice.

Authors:  A L Lamy; G J Fradet; A Luoma; B Nelems
Journal:  Ann Thorac Surg       Date:  1994-01       Impact factor: 4.330

View more
  20 in total

1.  The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).

Authors:  Tobias Else; Monica L Marvin; Jessica N Everett; Stephen B Gruber; H Alexander Arts; Elena M Stoffel; Richard J Auchus; Victoria M Raymond
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

Review 2.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

3.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

4.  Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.

Authors:  Victoria L Martucci; Zarina G Lorenzo; Michael Weintraub; Jaydira del Rivero; Alexander Ling; Maria Merino; Minhaj Siddiqui; Brian Shuch; Srinivas Vourganti; W Marston Linehan; Piyush K Agarwal; Karel Pacak
Journal:  Urol Oncol       Date:  2015-02-13       Impact factor: 3.498

Review 5.  Comprehensive review of evaluation and management of cardiac paragangliomas.

Authors:  Sri Harsha Tella; Abhishek Jha; David Taïeb; Keith A Horvath; Karel Pacak
Journal:  Heart       Date:  2020-05-22       Impact factor: 5.994

6.  Succinate dehydrogenase gene mutations in cardiac paragangliomas.

Authors:  Victoria L Martucci; Abbas Emaminia; Jaydira del Rivero; Ronald M Lechan; Bindiya T Magoon; Analyza Galia; Tito Fojo; Steve Leung; Roberto Lorusso; Camilo Jimenez; Barry L Shulkin; Jennifer L Audibert; Karen T Adams; Douglas R Rosing; Anand Vaidya; Robert G Dluhy; Keith A Horvath; Karel Pacak
Journal:  Am J Cardiol       Date:  2015-03-24       Impact factor: 2.778

Review 7.  Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.

Authors:  Graeme Eisenhofer; Arthur S Tischler; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

8.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 9.  SDH-related pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Kathryn S King; Karel Pacak
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

Review 10.  Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma.

Authors:  Veronica K Y Cheung; Anthony J Gill; Angela Chou
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.